Utah Administrative Code
Topic - Commerce
Title R156 - Professional Licensing
Rule R156-17b - Pharmacy Practice Act Rule
Section R156-17b-613 - Operating Standards - Issuing Prescription Orders by Electronic Means
Current through Bulletin 2024-24, December 15, 2024
In accordance with Rules R156-1 and R156-37, and Subsections 58-17b-102(29), 58-17b-102(30), 58-17b-602(1), prescription orders may be issued by electronic means of communication according to the following standards:
(1) Prescription orders for Schedule II - V controlled substances received by electronic communication shall be handled according to 21 CFR 1304.06 (2021).
(2) Prescription orders for non-controlled substances received by electronic communication may be dispensed by a pharmacist, pharmacy intern, or DMP only if the following conditions are satisfied:
(3) an electronically transmitted prescription order that meets the requirements of Subsection (2) shall be the original prescription.
(4) This section does not apply to the use of electronic equipment to transmit prescription orders within inpatient medical facilities.
(5) An agreement between a prescribing practitioner and a pharmacy may not require that prescription orders be transmitted by electronic means from the prescribing practitioner only to that pharmacy.
(6) The pharmacist or DMP shall retain a printed copy of an electronic prescription, or a record of an electronic prescription that is readily retrievable and printable, for a minimum of five years. The printed copy shall be of non-fading legibility.
(7) Wholesalers, distributors, manufacturers, pharmacists, and pharmacies may not supply electronic equipment to a prescriber for transmitting prescription orders.
(8) An electronically transmitted prescription order shall be transmitted to the pharmacy of the patient's choice.
(9) Prescription orders electronically transmitted to the pharmacy by the patient may not be filled or dispensed.
(10) A prescription order for a legend drug or controlled substance in Schedule III through V may be transferred up to the maximum refills permitted in accordance with 21 CFR 1306.22 (2021) or by the prescriber by electronic transmission, if: